Page 9 - Doug Schultz News Today

When given early, lab-engineered antibody infusions have reduced COVID-19 hospitalizations among persons at high risk. Previous versions of these treatments do not appear to work against the omicron variant, however. Replacement products are in short supply, with providers given a few dozen treatments weekly while managing hundreds of new patients.

When given early, lab-engineered antibody infusions have reduced COVID-19 hospitalizations among persons at high risk. Previous versions of these treatments do not appear to work against the omicron variant, however. Replacement products are in short supply, with providers given a few dozen treatments weekly while managing hundreds of new patients.

When given early, lab-engineered antibody infusions have reduced COVID-19 hospitalizations among persons at high risk. Previous versions of these treatments do not appear to work against the omicron variant, however. Replacement products are in short supply, with providers given a few dozen treatments weekly while managing hundreds of new patients.

There's no way to report a positive at-home rapid test in the state.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.

Rapid antigen kits may be running off the shelves, but with omicron, the meaning of both negative and positive results are changing.